Photo by henrylim from unsplash
To compare the effects of monotherapy with intravitreal ranibizumab, aflibercept and bevacizumab on retinal ganglion cell layer (RGCL) and retinal nerve fibre layer (RNFL) in patients with naïve neovascular age‐related… Click to show full abstract
To compare the effects of monotherapy with intravitreal ranibizumab, aflibercept and bevacizumab on retinal ganglion cell layer (RGCL) and retinal nerve fibre layer (RNFL) in patients with naïve neovascular age‐related macular degeneration (nAMD).
Keywords:
intravitreal ranibizumab;
bevacizumab retinal;
layer;
aflibercept bevacizumab;
retinal ganglion;
ranibizumab aflibercept
Journal Title: Acta Ophthalmologica
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Acta Ophthalmologica
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!